Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Osmosis AI serves as an interactive study companion seamlessly integrated into the Osmosis learning platform, aimed at assisting medical and health professional students in grasping, reviewing, and solidifying intricate subjects through a mix of AI-driven explanations and reputable educational resources. It combines Elsevier's vast collection of peer-reviewed medical textbooks and materials with the Osmosis visual learning approach, providing responses that are evidence-based, properly cited, and linked to pertinent videos, diagrams, and study aids. This innovative tool allows students to inquire in real time without disrupting their study routine, offering straightforward explanations in accessible language along with direct citations to the original sources for validation. Unlike many platforms that depend on open web data, Osmosis AI functions within a defined "walled garden" of carefully selected medical content, minimizing the occurrence of inaccuracies and ensuring alignment with the educational standards for teaching and assessment in the medical field. As a result, students can engage in a more focused and reliable learning experience that enhances their understanding of complex topics.
Description
Recursion is a leading TechBio innovator using artificial intelligence to radically improve how new medicines are discovered and developed. The company was founded on the idea that images of cells could be used to train AI systems to understand disease biology at scale. By combining data, machine learning models, and powerful computing, Recursion works to overcome the inefficiencies of traditional drug discovery. Its Recursion OS platform connects massive proprietary biological datasets with automated experimentation and AI-driven insights. This approach has produced a growing pipeline of potential therapies for oncology and rare diseases with high unmet medical needs. Recursion has demonstrated significant gains in speed, efficiency, and cost reduction compared to conventional pharmaceutical methods. Strategic partnerships with pharmaceutical companies and technology leaders expand the reach of its platform. The company also collaborates with NVIDIA to power its discovery efforts using BioHive-2, one of the most advanced supercomputers in biopharma. Together, these capabilities position Recursion as a leader in AI-driven drug discovery. Its ultimate goal is to deliver better medicines to patients through precision design and data-driven science.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Yes
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
No
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
No
In Person
Yes
Vendor Details
Company Name
Elsevier
Founded
1880
Country
The Netherlands
Website
www.elsevier.com/products/osmosis/osmosis-ai
Vendor Details
Company Name
Recursion
Country
United States
Website
www.recursion.com